Page last updated: 2024-09-03

ulipristal acetate and cholecalciferol

ulipristal acetate has been researched along with cholecalciferol in 3 studies

Compound Research Comparison

Studies (ulipristal acetate)	Trials (ulipristal acetate)	Recent Studies (post-2010) (ulipristal acetate)	Studies (cholecalciferol)	Trials (cholecalciferol)	Recent Studies (post-2010) (cholecalciferol)
376	41	347	8,234	1,425	3,471

Protein Interaction Comparison

Protein	Taxonomy	ulipristal acetate (IC50)	cholecalciferol (IC50)
Vitamin D3 receptor	Homo sapiens (human)		0.087

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Centini, G; Kashani, BN; Morelli, SS; Petraglia, F; Weiss, G	1
Ciebiera, M; Jakiel, G; Męczekalski, B; Łukaszuk, K	1
Alemari, NBA; Arık, GN; Fındık, DG; Kaplanoğlu, GT	1

Reviews

1 review(s) available for ulipristal acetate and cholecalciferol

Article	Year
Role of Medical Management for Uterine Leiomyomas. Best practice & research. Clinical obstetrics & gynaecology, 2016, Volume: 34 Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins	2016

Article

Year

Role of Medical Management for Uterine Leiomyomas.

Best practice & research. Clinical obstetrics & gynaecology, 2016, Volume: 34

Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins

2016

Other Studies

2 other study(ies) available for ulipristal acetate and cholecalciferol

Article	Year
Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy - 2 case studies. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2019, Volume: 35, Issue:6 Topics: Adult; Antineoplastic Agents, Hormonal; Cholecalciferol; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leiomyomatosis; Middle Aged; Norpregnadienes; Treatment Outcome; Uterine Neoplasms	2019
Decreased growth differentiation factor 9, bone morphogenetic protein 15, and forkhead box O3a expressions in the ovary via ulipristal acetate. Revista da Associacao Medica Brasileira (1992), 2023, Volume: 69, Issue:8 Topics: Animals; Anti-Mullerian Hormone; Bone Morphogenetic Protein 15; Cholecalciferol; Female; Forkhead Box Protein O3; Growth Differentiation Factor 9; Ovary; Rats; Rats, Wistar	2023

Article

Year

Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy - 2 case studies.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2019, Volume: 35, Issue:6

Topics: Adult; Antineoplastic Agents, Hormonal; Cholecalciferol; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leiomyomatosis; Middle Aged; Norpregnadienes; Treatment Outcome; Uterine Neoplasms

2019

Decreased growth differentiation factor 9, bone morphogenetic protein 15, and forkhead box O3a expressions in the ovary via ulipristal acetate.

Revista da Associacao Medica Brasileira (1992), 2023, Volume: 69, Issue:8

Topics: Animals; Anti-Mullerian Hormone; Bone Morphogenetic Protein 15; Cholecalciferol; Female; Forkhead Box Protein O3; Growth Differentiation Factor 9; Ovary; Rats; Rats, Wistar

2023